How should intermittent left‑arm weakness be evaluated and managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: February 5, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What is the appropriate evaluation and management for a 26-year-old patient presenting with muscle twitching?

What is the ABCD2 score and recommended early antiplatelet therapy for a 60‑year‑old woman with pre‑diabetes who presented with a high‑risk transient ischemic attack?

What are the current guidelines for medication management in a 65-year-old male admitted for Transient Ischemic Attack (TIA) evaluation?

What is the immediate management for a patient who has already suffered a brain infarction (cerebral infarction)?

What is the most likely diagnosis and recommended acute management for a 60‑year‑old female with pre‑diabetes who presents with abrupt memory lapses and dysarthria, no focal weakness, blood pressure 160/90 mmHg, and a non‑acute CT showing chronic microvascular changes?

What is the recommended treatment for a patient with confirmed Clostridioides difficile colitis, including initial therapy, management of severe disease, and recurrence prevention?

How should a child with first‑day acute bronchitis, afebrile, and expiratory wheeze be managed?

What are leukocytes and what is the normal adult leukocyte count?

What is the diagnostic and treatment approach for C. difficile infection in a patient without diarrhea but with ileus or toxic megacolon, abdominal pain, fever, leukocytosis, recent broad‑spectrum antibiotic exposure, and colonic wall thickening on imaging?

What is the recommended initial management for a new lumbar vertebral compression fracture?

What is the recommended dosing schedule, administration requirements, and contraindications for Bellsomra (esketamine) nasal spray in adults with treatment‑resistant major depressive disorder?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.